189 related articles for article (PubMed ID: 26560746)
1. Continuous infusion of factor VIII concentrates in obese patients with severe haemophilia A: is weight-based dose-adjustment required?
Boban A; Henrard S; Lambert C; Hermans C
Haemophilia; 2016 Jan; 22(1):e62-4. PubMed ID: 26560746
[No Abstract] [Full Text] [Related]
2. Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia.
Park YS; Shin WJ; Kim KI
BMC Musculoskelet Disord; 2017 Aug; 18(1):356. PubMed ID: 28830476
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII.
Takedani H
Haemophilia; 2010 Sep; 16(5):740-6. PubMed ID: 20398072
[TBL] [Abstract][Full Text] [Related]
4. Severe postoperative haemarthrosis following a total knee replacement in a haemophiliac patient caused by a pseudoaneurysm: early treatment with arterial embolization.
Rodriguez-Merchan EC; Jimenez-Yuste V; Gomez-Cardero P; Rodriguez T
Haemophilia; 2014 Jan; 20(1):e86-9. PubMed ID: 24165398
[No Abstract] [Full Text] [Related]
5. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study.
Auerswald G; Bade A; Haubold K; Overberg D; Masurat S; Moorthi C
Haemophilia; 2013 May; 19(3):438-44. PubMed ID: 23279056
[TBL] [Abstract][Full Text] [Related]
6. Evidence-Based Minireview: For overweight or obese persons with hemophilia A, should factor VIII dosing be based on ideal or actual body weight?
Machin N; Lim MY
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):215-218. PubMed ID: 34889357
[No Abstract] [Full Text] [Related]
7. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
Lowe GD
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.
Meijer K; Rauchensteiner S; Santagostino E; Platokouki H; Schutgens RE; Brunn M; Tueckmantel C; Valeri F; Schinco PC
Haemophilia; 2015 Jan; 21(1):e19-25. PubMed ID: 25458982
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic analysis of anti-hemophilic factor in the obese patient.
Graham A; Jaworski K
Haemophilia; 2014 Mar; 20(2):226-9. PubMed ID: 24252161
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion of factor VIII for surgery and major bleeding.
Hay CR; Doughty HI; Savidge GF
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
[TBL] [Abstract][Full Text] [Related]
11. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A.
Stine KC; Becton DL
Haemophilia; 2006 Jul; 12(4):435-6. PubMed ID: 16834747
[TBL] [Abstract][Full Text] [Related]
12. High responding factor VIII inhibitors in mild haemophilia - is there a link with recent changes in clinical practice?
White B; Cotter M; Byrne M; O'Shea E; Smith OP
Haemophilia; 2000 Mar; 6(2):113-5. PubMed ID: 10781199
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII concentrate infusion in patients with haemophilia results in decreased von Willebrand factor and ADAMTS-13 activity.
van Bladel ER; Tuinenburg A; Roest M; de Groot PG; Schutgens RE
Haemophilia; 2014 Jan; 20(1):92-8. PubMed ID: 24028772
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic model for factor VIII dosing during active haemorrhage in patients with haemophilia A.
Ho AM; Dion P; Karmakar MK; Cheng G; Derrick JL; Chung DC; Tay BA
Anaesthesia; 2001 Aug; 56(8):785-90. PubMed ID: 11493246
[TBL] [Abstract][Full Text] [Related]
15. Haemostatic response to factor VIII administration in patients with haemophilia A measured by thrombin generation and correlation with factor concentrate use.
Hugenholtz GC; Luddington R; Baglin T
Haemophilia; 2016 Jan; 22(1):e42-5. PubMed ID: 26388112
[No Abstract] [Full Text] [Related]
16. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.
Martinowitz U; Schulman S; Gitel S; Horozowski H; Heim M; Varon D
Br J Haematol; 1992 Dec; 82(4):729-34. PubMed ID: 1482660
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgery.
Preijers T; Laros-vanGorkom BA; Mathôt RA; Cnossen MH
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642854
[TBL] [Abstract][Full Text] [Related]
18. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
Bloom AL; Emmanuel JH
Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
[No Abstract] [Full Text] [Related]
19. Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion.
Tagariello G; Davoli PG; Gajo GB; De Biasi E; Risato R; Baggio R; Traldi A
Haemophilia; 1999 Nov; 5(6):426-30. PubMed ID: 10583530
[TBL] [Abstract][Full Text] [Related]
20. Continuous intravenous infusion of factor VIII in classic haemophilia.
McMillan CW; Webster WP; Roberts HR; Blythe WB
Br J Haematol; 1970 Jun; 18(6):659-67. PubMed ID: 5428626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
